Weight Loss
Conditions
Keywords
fat oxidation, hunger, resistant starch, whey protein
Brief summary
Recent evidence shows that dietary supplementation with resistant starch (RS) increases fat catabolism and resting energy expenditure and decreases plasma insulin and glucose responses as well as the gut-derived hormone, glucose-dependent insulinotropic polypeptide (GIP). Consumption of whey protein has also been shown to increase energy expenditure and favorably affect gut hormones. Thus, investigators tested consumption of both RS and whey protein on energy expenditure and gut hormones in lean and obese women and men.
Detailed description
Consumed separately, resistant starch (RS) and whey protein (WP) favorably affect energy metabolism and gut hormones, as well as suppress feelings of hunger. These findings are important because release of certain gut hormones (i.e., GIP) is associated with a lower resting energy expenditure (REE) in healthy humans. Interestingly, a recent study showed that ingestion of RS reduces postprandial GIP and increases postprandial REE and fat utilization in healthy men and therefore may be an effective strategy in weight management. Thus, there is a need to replicate these findings in a healthy cohort of lean and obese women and men. The purpose of this study was to examine the effects of RS on the number of calories burned after eating a meal, as well as specific hormones that are released from the stomach and intestines following meal ingestion in healthy lean and obese women and men. Investigators used a single ingestion of a meal supplemented with or without the resistant starch and whey protein.
Interventions
pancake test meal with waxy maize starch only
pancake test meal with waxy maize starch and whey protein
pancake test meal with resistant starch only
pancake test meal with resistant starch and whey protein
Sponsors
Study design
Eligibility
Inclusion criteria
* overweight or lean but otherwise healthy
Exclusion criteria
* Participants will be excluded if they smoke; have experienced excessive weight loss/gain of \> ±2kg in the previous 2 months; are currently taking medications for cardiovascular or metabolic disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in fat oxidation from Baseline to 180 Minutes Postprandial | time 0, 60, 120, 180 minutes | indirect calorimetry of fuel utilization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in gut hormones from Baseline to 180 Minutes Postprandial | time 0, 60, 120, 180 minutes | gastro-entero-pancreatic hormones |
| Change in self-reported feelings of hunger, fullness, satiation from Baseline to 180 Minutes Postprandial | time 0, 60, 120, 180 minutes | visual analog scale of hunger, fullness and satiation |